USPTO serial 85926577
V VETTER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 11, 2014
- Examiner
- HWANG, JOHN C B
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with V VETTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
Ravensburg, DE
Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
Ravensburg, DE
Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
VETTER PHARMA-FERTIGUNG GMBH & CO. KG
RAVENSBURG, DE
Other trademarks owned by VETTER PHARMA-FERTIGUNG GMBH & CO. KG
VETTER PHARMA-FERTIGUNG GMBH & CO. KG
RAVENSBURG, DE
Other trademarks owned by VETTER PHARMA-FERTIGUNG GMBH & CO. KG
ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
Ravensburg, DE
Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations and medicaments, solutions for oral use, sterile solutions and solutions for injections all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; pharmaceutical preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinase, factor VIII, gnrh analogs, and recombinant proteins eye drops, solutions for contact lenses all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; fillings of liquid, semi-solid or solid substances, namely, pharmaceutical preparations in solvated form as solutions with active agents, as powders with solvent or as lyophilistates with solvent in injection systems, namely, in injection syringes and instruments for infections, injectors, injector pens as well as in single chamber, double chamber and disposable syringes, as well as solutions for oral use as well as sterile solutions, solutions for injections including aseptic filling of injection solutions all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; preparations containing heparins, vaccines, calcitonins, prostaglandins, anaesthestics, reconstruction diluents, human growth hormone, monoclonal antibodies, epo, urokinase, factor VIII, gnrh analogs, and recombinant proteins all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, kidney disease, intestinal disorder, lung and bronchial disorder, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; tampons with and without disinfectants and bandages separately or jointly packed, and in sterile packages ] | SECTION 8 - CANCELLED | — |
| 007 | [ Machine tools, motors, couplings and clutches, drive belts, filling machines, labeling machines packaging machines, box-making machines ALL for erecting, filling and closing of cardboard and foldable boxes; machines for washing, filling and closing medical syringes and vials; INDUSTRIAL robots; mechanical transport machines for the transfer of containers between processing stations, and thermoforming machines for producing, filling and sealing of blister packaging; and machines for controlling the supply and filling of goods in containers ] | SECTION 8 - CANCELLED | — |
| 010 | Medical injection systems, namely, syringes and instruments for injections, injectors, injection pens auto-injectors as well as single chamber and double chamber disposable syringes, all sold empty; containers for medicaments made from glass and/or plastics and syringe holders for ready-to-use syringes for picking-up and handling of syringes | ACTIVE | — |
| 042 | Design and development of injection syringes and instruments and injectors and corresponding packages; chemical and microbiological analyses for scientific and forensic research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
- Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
- Other trademarks owned by VETTER PHARMA-FERTIGUNG GMBH & CO. KG
- Other trademarks owned by VETTER PHARMA-FERTIGUNG GMBH & CO. KG
- Other trademarks owned by ARZNEIMITTEL GMBH APOTHEKER VETTER & CO. RAVENSBURG
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named V VETTER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 24, 2024 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jan 24, 2024 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jan 24, 2024 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jan 23, 2024 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Feb 11, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 6, 2020 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 29, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 3, 2020 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 3, 2020 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 2, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 7, 2020 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 11, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 11, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 26, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 26, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 6, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 17, 2013 | ALIE | ASSIGNED TO LIE | — |
| Oct 2, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 2, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 2, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 30, 2013 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Aug 30, 2013 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Aug 30, 2013 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Aug 30, 2013 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Aug 26, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2013 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 14, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2013 | NWAP | NEW APPLICATION ENTERED | — |